Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Citatuzumab bogatox (VB6-845) is a recombinant immunotoxin consisting of a humanized antibody's Fab fragment targeting EpCAM and a modified bouganin cytotoxin. It selectively binds to EpCAM-positive cell lines, inducing apoptosis, and demonstrates efficacy in EpCAM-positive human tumor xenograft models [1] [2] [3].
説明 | Citatuzumab bogatox (VB6-845) is a recombinant immunotoxin consisting of a humanized antibody's Fab fragment targeting EpCAM and a modified bouganin cytotoxin. It selectively binds to EpCAM-positive cell lines, inducing apoptosis, and demonstrates efficacy in EpCAM-positive human tumor xenograft models [1] [2] [3]. |
分子量 | N/A |
CAS No. | 945228-49-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Citatuzumab bogatox 945228-49-9 Inhibitor inhibitor inhibit